These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8350194)
1. In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins. König K; Schneckenburger H; Rück A; Steiner R J Photochem Photobiol B; 1993 May; 18(2-3):287-90. PubMed ID: 8350194 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Hua Z; Gibson SL; Foster TH; Hilf R Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of experimental colonic tumours with 5-aminolevulinic-acid-induced endogenous porphyrins. Orth K; König K; Genze F; Rück A J Cancer Res Clin Oncol; 1994; 120(11):657-61. PubMed ID: 7962041 [TBL] [Abstract][Full Text] [Related]
4. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy. Xiao Z; Miller GG; McCallum TJ; Brown KM; Lown JW; Tulip J; Moore RB Photochem Photobiol; 1998 May; 67(5):573-83. PubMed ID: 9613241 [TBL] [Abstract][Full Text] [Related]
5. The photosensitizing effect of the photoproduct of protoporphyrin IX. Ma L; Bagdonas S; Moan J J Photochem Photobiol B; 2001 Jul; 60(2-3):108-13. PubMed ID: 11470566 [TBL] [Abstract][Full Text] [Related]
6. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model. Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429 [TBL] [Abstract][Full Text] [Related]
7. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect. Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268 [TBL] [Abstract][Full Text] [Related]
8. Fluorescence spectroscopy of normal mouse skin exposed to 5-aminolaevulinic acid and red light. Juzenas P; Iani V; Bagdonas S; Rotomskis R; Moan J J Photochem Photobiol B; 2001 Aug; 61(1-2):78-86. PubMed ID: 11485851 [TBL] [Abstract][Full Text] [Related]
9. Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines. Sailer R; Strauss WS; Wagner M; Emmert H; Schneckenburger H Photochem Photobiol Sci; 2007 Feb; 6(2):145-51. PubMed ID: 17277837 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice. Pech O; Nagy CD; Gossner L; May A; Ell C Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):657-62. PubMed ID: 12072600 [TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration. Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254 [TBL] [Abstract][Full Text] [Related]
12. Phototransformations of 5-aminolevulinic acid-induced protoporphyrin IX in vitro: a spectroscopic study. Bagdonas S; Ma LW; Iani V; Rotomskis R; Juzenas P; Moan J Photochem Photobiol; 2000 Aug; 72(2):186-92. PubMed ID: 10946571 [TBL] [Abstract][Full Text] [Related]
14. Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells. Bachor R; Reich E; Rück A; Hautmann R Urol Res; 1996; 24(5):285-9. PubMed ID: 8931293 [TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222 [TBL] [Abstract][Full Text] [Related]
16. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser. Shen SC; Lee WR; Fang YP; Hu CH; Fang JY J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590 [TBL] [Abstract][Full Text] [Related]
17. Application of 5-aminolevulinic acid and its derivatives for photodynamic therapy in vitro and in vivo. Juzeniene A; Juzenas P; Moan J Methods Mol Biol; 2010; 635():97-106. PubMed ID: 20552342 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder. Leveckis J; Burn JL; Brown NJ; Reed MW J Urol; 1994 Aug; 152(2 Pt 1):550-3. PubMed ID: 8015110 [TBL] [Abstract][Full Text] [Related]
19. The importance of fluorescence distribution and kinetics of ALA-induced PpIX in the bladder in photodynamic therapy. Grönlund-Pakkanen S; Mäkinen K; Talja M; Kuusisto A; Alhava E J Photochem Photobiol B; 1997 Apr; 38(2-3):269-73. PubMed ID: 9203390 [TBL] [Abstract][Full Text] [Related]
20. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. De Rosa FS; Marchetti JM; Thomazini JA; Tedesco AC; Bentley MV J Control Release; 2000 Apr; 65(3):359-66. PubMed ID: 10699294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]